Search Results 61-70 of 17042 for ibs
About this study. The purpose of this study is to measure 48 hour fecal bile acids in IBS-D adolescents and compare it to HC; measure serum C4 and FGF-19 in ...
... (IBS) based on the Rome III criteria and to determine fecal microbiota changes in concordant and discordant twins with IBS. Participation eligibility.
... Irritable Bowel Syndrome (IBS-D). Print details. Share; Facebook · Twitter ... IBS-D. Participation eligibility. Participant eligibility includes age, gender ...
Alosetron is used to treat irritable bowel syndrome (IBS) in women who have diarrhea as their main symptom. This medicine is only used in severe cases of IBS ...
difficile disease (rCDI) and using a combination of clinical and laboratory markers to determine disease versus post infectious irritable bowel syndrome (IBS) ...
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome · Overview · Participation eligibility.
There are new approaches to manage the frustrating symptoms of irritable bowel syndrome (IBS), according to the November issue of Mayo Clinic Health Letter.
Will Ranolazine improve bowel function and abdominal pain in human subjects with IBS-D? Participation eligibility. Participant eligibility includes age ...
A study to determine if adult patients with IBS-C will report an overall greater improvement in IBS quality of life when treated with a combination of ...
About this study. The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating IBS-D in pediatric patients 12-17 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation can make a difference in the future of healthcare. Give now to support Mayo Clinic's research.